Rigel Pharmaceuticals Inc. Common Stock (RIGL)

Stock · NASDAQ · Health Care

$46.48as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$29.75

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

RIGL
Rigel Pharmaceuticals Inc. Common Stock
$46.48
▼ 0.81%
Market cap $692.53MP/E —
CTMX
CytomX Therapeutics Inc. Common Stock
$3.22
▼ 5.99%
Market cap $690.12MP/E —
$1.9$8.21
OCS
Oculis Holding AG Ordinary shares
$12.21
▼ 1.77%
Market cap $689.43MP/E —
$10.52$34.48
CLYM
Climb Bio Inc. Common Stock
$14.56
▼ 3.32%
Market cap $676.28MP/E —
$1.54$18.33
DRUG
Bright Minds Biosciences Inc. Common Stock
$72.74
▼ 2.41%
Market cap $723.93MP/E —
$53.99$170
BBOT
BridgeBio Oncology Therapeutics Inc. Common Stock
$8.74
▼ 4.79%
Market cap $660.88MP/E —
$7$14.87
MNPR
Monopar Therapeutics Inc. Common Stock
$112.17
▼ 1.55%
Market cap $747.88MP/E —
$32.77$124.82

Symbol	Market cap	P/E ratio	Price	1D	52-week range
RIGL Rigel Pharmaceuticals Inc. Common Stock	$692.53M	—	$46.48	▼ 0.81%
CTMX CytomX Therapeutics Inc. Common Stock	$690.12M	—	$3.22	▼ 5.99%	$1.9$8.21
OCS Oculis Holding AG Ordinary shares	$689.43M	—	$12.21	▼ 1.77%	$10.52$34.48
CLYM Climb Bio Inc. Common Stock	$676.28M	—	$14.56	▼ 3.32%	$1.54$18.33
DRUG Bright Minds Biosciences Inc. Common Stock	$723.93M	—	$72.74	▼ 2.41%	$53.99$170
BBOT BridgeBio Oncology Therapeutics Inc. Common Stock	$660.88M	—	$8.74	▼ 4.79%	$7$14.87
MNPR Monopar Therapeutics Inc. Common Stock	$747.88M	—	$112.17	▼ 1.55%	$32.77$124.82

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.